Apollomics Competitors and Similar CompaniesClear all
Apollomics's competitors and similar companies include Milo Biotechnology, Sujana BioTech, Marker Therapeutics and Esperance Pharmaceuticals.
 Apollomics Apollomics (formerly known as CBT Pharmaceuticals) is a biopharmaceutical company committed to developing medicines targeting the growth and proliferation of cancer cells. |  Milo Biotechnology Milo Biotechnology is a mid-clinical-stage company developing drugs for multiple muscle wasting disorders. |  Sujana BioTech Sujana Biotech is a biotechnology company developing monoclonal antibodies and small-molecule inhibitors for a range of inflammatory, vascular, and autoimmune disorders. |  Marker Therapeutics Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. |  Esperance Pharmaceuticals Esperance Pharmaceuticals is a company developing a class of targeted anticancer drugs. | |
Founding Date | Founding Date 2015 | Founding Date 2010 | Founding Date 2015 | Founding Date 2018 | Founding Date 2006 |
Type | Type Public | Type Private | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Foster City, US HQ Southbank, AU Hangzhou, CN Shanghai, CN | Locations Cleveland, US HQ | Locations Shaker Heights, US HQ | Locations Houston, US HQ | Locations Houston, US HQ |
Employees | Employees 1371% decrease | Employees 1 | Employees N/A | Employees 888% decrease | Employees 8 |
Valuation ($) | Valuation ($) 14.6 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 36.5 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $8.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($10.9m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($12.2m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 800k (over 9 years ago) | Latest funding round $ 800k (about 11 years ago) | Latest funding round N/A | Latest funding round $ 7.5m (almost 15 years ago) |
Total funding raised | Total funding raised $ 238.8m | Total funding raised $ 1.5m | Total funding raised $ 800k | Total funding raised N/A | Total funding raised $ 28.7m |
For sources of this data, please see the company profile
View Company Profiles
Milo Biotechnology
HQ
Cleveland, US
Employees
1
Milo Biotechnology is a mid-clinical-stage company developing drugs for multiple muscle wasting disorders.
View companySujana BioTech
HQ
Shaker Heights, US
Sujana Biotech is a biotechnology company developing monoclonal antibodies and small-molecule inhibitors for a range of inflammatory, vascular, and autoimmune disorders.
View companyMarker Therapeutics
HQ
Houston, US
Employees
8
Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection.
View companyEsperance Pharmaceuticals
HQ
Houston, US
Employees
8
Esperance Pharmaceuticals is a company developing a class of targeted anticancer drugs.
View company